Search

NeoGenomics Inc

Aperta

SettoreSettore sanitario

19.01 1.82

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

18.42

Massimo

19

Metriche Chiave

By Trading Economics

Entrata

19M

2.2M

Vendite

15M

202M

EPS

-0.01

Margine di Profitto

1.11

Dipendenti

2,500

EBITDA

19M

19M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

-2.95% downside

Dividendi

By Acuity

Utili prossimi

27 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

783M

2.5B

Apertura precedente

17.19

Chiusura precedente

19.01

Notizie sul Sentiment di mercato

By Acuity

87%

13%

310 / 339 Classifica in Healthcare

NeoGenomics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 set 2026, 20:07 UTC

News

Neogenomics Inc shares fell sharply, declining since Monday's close, despite early session gains and interest in its strategic shift towards precision oncology.

21 set 2026, 21:21 UTC

Neogenomics Inc is trading modestly lower in after-market hours, declining from an initial high despite being above its 20-day moving average.

17 set 2026, 20:07 UTC

Correlated Moves

Neogenomics Inc is advancing, supported by gains in the ARK Genomic Revolution ETF and positive broader market trends, marking five consecutive sessions of gains.

15 set 2026, 20:07 UTC

Neogenomics Inc's shares are higher today, reflecting a notable increase since Monday's close. The stock remains above its 20-day moving average.

14 set 2026, 23:46 UTC

Neogenomics Inc shares are modestly higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

11 set 2026, 21:01 UTC

Neogenomics Inc shares declined in after-market trading, coinciding with a significant drop in the Michigan Consumer Sentiment Index. No specific company news was identified.

10 set 2026, 20:07 UTC

Neogenomics Inc shares are lower today amid a broader market decline and rising Treasury yields, with no specific company news identified.

9 set 2026, 20:07 UTC

Neogenomics Inc's shares are higher Wednesday, despite an earlier pullback. No specific company news was identified to explain the price movement.

8 set 2026, 19:26 UTC

Neogenomics Inc shares are higher today, continuing gains since Friday. The stock remains above its 20-day moving average and within its one-month range.

4 set 2026, 23:20 UTC

Neogenomics Inc shares are higher in after-market trading, reflecting strong performance since Friday's close and positioning above its 20-day moving average.

2 set 2026, 20:08 UTC

Neogenomics Inc is lower in Wednesday's session, continuing a trend of four consecutive declines. No specific news was identified to explain the move.

1 set 2026, 20:08 UTC

Neogenomics Inc shares are lower today, continuing a downward trend since Monday. No specific company news was identified to explain the decline.

31 ago 2026, 20:07 UTC

Social Media

Neogenomics Inc shares are lower amid rising interest rate hike expectations following recent economic commentary. Earlier, the stock rebounded from a session high.

28 ago 2026, 20:51 UTC

Neogenomics Inc's shares are higher in after-market hours, moving significantly above their 20-day moving average and near the upper end of their one-month range.

27 ago 2026, 23:01 UTC

Neogenomics Inc. shares are higher in after-market trading, reflecting notable strength following Thursday's close. The stock remains above its 20-day moving average.

26 ago 2026, 23:01 UTC

News

Neogenomics Inc secures expanded Medicare coverage for RaDaR ST assay, enhancing immunotherapy monitoring. Shares are trading higher in after-market hours.

25 ago 2026, 23:02 UTC

Neogenomics Inc is trading higher in after-market hours, remaining near the upper end of its one-month range and above its 20-day moving average.

24 ago 2026, 23:06 UTC

Neogenomics Inc shares are lower in after-market trading, with no specific news identified. Broader market concerns include the U.S.-Iran conflict and oil supply disruptions.

21 ago 2026, 20:06 UTC

Neogenomics shares are higher, benefiting from a strong trend in the Health Care Services sub-sector, despite no specific company news identified.

20 ago 2026, 21:26 UTC

Neogenomics Inc's shares are higher in after-market trading, maintaining a stable performance since Thursday's close amid no specific news or developments.

19 ago 2026, 19:26 UTC

Neogenomics Inc shares are higher today amid strong buying interest. The stock is approaching the upper end of its one-month trading range.

18 ago 2026, 19:36 UTC

Neogenomics Inc shares are lower today amid broader economic concerns, including rising treasury yields and inflation pressures. The stock reached a session low earlier.

17 ago 2026, 22:01 UTC

Neogenomics Inc is rising in after-market trading, reflecting a strong performance following Monday's close amid a generally positive trading environment and heightened volatility.

14 ago 2026, 23:01 UTC

Neogenomics Inc shares are lower in after-market hours, following a decline influenced by mixed market sentiment and a drop in U.S. retail sales.

13 ago 2026, 22:02 UTC

Neogenomics Inc. shares fell in after-market trading, declining since Thursday's close, despite broader market averages closing higher earlier in the day.

12 ago 2026, 23:51 UTC

Neogenomics Inc shares are higher in after-market trading, maintaining a strong upward trajectory since Wednesday's close, despite no specific news identified.

11 ago 2026, 19:26 UTC

Neogenomics Inc. shares are lower today, with no specific news identified. Investors await U.S. inflation reports that may impact market sentiment.

10 ago 2026, 22:26 UTC

Neogenomics Inc shares are higher in after-market trading, remaining above their 20-day moving average despite no specific news. Rising Treasury yields may influence sentiment.

7 ago 2026, 20:03 UTC

Neogenomics Inc shares are higher during Friday's session, reflecting strong market performance. The stock has advanced since Thursday's close, despite a recent pullback.

6 ago 2026, 21:51 UTC

Neogenomics Inc shares are higher in after-market trading, reaching a notable high and remaining above their 20-day moving average. No specific news was identified.

Confronto tra pari

Modifica del prezzo

NeoGenomics Inc Previsione

Obiettivo di Prezzo

By TipRanks

-2.95% in calo

Previsioni per 12 mesi

Media 18.333 USD  -2.95%

Alto 21 USD

Basso 16 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per NeoGenomics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

8 ratings

5

Acquista

3

Mantieni

0

Vendi

Sentiment

By Acuity

310 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.